✦ LIBER ✦

Randomized, Double-Blind Placebo- and Tolterodine-Controlled Trial of the Once-Daily Anti-muscarinic Agent Solifenacin in Patients With Symptomatic Overactive Bladder

Book ID: 122455655
Publisher: Lippincott Williams and Wilkins
Year: 2004
Tongue: English
Weight: 59 KB
Volume: 172
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(05)61623-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, double-blind placebo- and to

Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder

✍ C.R. Chapple; T. Rechberger; S. Al-Shukri; P. Meffan; K. Everaert; M. Huang; A. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

RANDOMIZED, DOUBLE-BLIND PLACEBO CONTROL

RANDOMIZED, DOUBLE-BLIND PLACEBO CONTROLLED TRIAL OF THE ONCE DAILY ANTIMUSCARINIC AGENT SOLIFENACIN SUCCINATE IN PATIENTS WITH OVERACTIVE BLADDER

✍ CARDOZO, L.; LISEC, M.; MILLARD, R.; van VIERSSEN TRIP, O.; KUZMIN, I.; DROGENDI 📂 Article 📅 2004 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 793 KB

Randomized, double-blind, placebo- and p

Randomized, double-blind, placebo- and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder

✍ Osamu Yamaguchi; Eiji Marui; Hidehiro Kakizaki; Naoki Itoh; Takashi Yokota; Hiro 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB

Efficacy and safety of solifenacin succi

Efficacy and safety of solifenacin succinate 10 mg once Daily: A multicenter, phase III, randomized, double-blind, placebo-controlled, parallel-group trial in patients with overactive bladder

✍ Franklin Chu; Neila Smith; Takeshi Uchida 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 141 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled phase II dose-finding study of the novel anti-muscarinic agent imidafenacin in Japanese patients with overactive bladder

✍ Yukio Homma; Takuhiro Yamaguchi; Osamu Yamaguchi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

A randomized, double-blind, placebo- and

A randomized, double-blind, placebo- and propiverine-controlled trial of the novel antimuscarinic agent imidafenacin in Japanese patients with overactive bladder

✍ Yukio Homma; Osamu Yamaguchi; Imidafenacin Study Group 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB